The FDA has delayed tolebrutinib’s review date again, as Sanofi also posted a Phase III failure for the MS candidate.

Zacks Market Edge is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by ...

Oracle (ORCL) reported its Q2 earnings on December 10, after market close. The earnings report disappointed investors, and ...

Microsoft Corporation, Oracle Corporation, Warner Bros Discovery Inc, NVIDIA Corporation. Read 's Market Analysis on Investing.com ...

This article will be updated throughout the day, so check back often for more daily updates. The Vanguard S&P 500 ETF ...

Tracey Ryniec and Zacks Chief Equity Strategist, John Blank, look at the US economy and 5 stocks to buy in 2026.

Despite a significant revenue miss and a 10% stock decline, Oracle’s fundamentals are stronger than ever when taking into ...

Micron Technology, Inc. MU will report first-quarter fiscal 2026 results on Dec. 17, after market close. The company projects fiscal first-quarter revenues to be $12.5 billion (+/- $300 million). The ...

Nvidia's data center business could end up outperforming expectations in 2026, paving the way for a bigger increase than the ...

Live Updates Get The Best Oracle Live Earnings Coverage Like This Every Quarter Get earnings reminders, our top analysis on ...

The transcript of Oracle’s second quarter FY2026 earnings call is below: This transcript is brought to you by Benzinga APIs.

The semiconductor sector delivered extraordinary performance in 2025, with AI-driven demand reshaping the competitive ...